Curcuminoid binding to embryonal Carcinoma cells: Reductive metabolism, induction of apoptosis, senescence, and inhibition of cell proliferation

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Quitschke, Wolfgang W ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; CURCUMINOID; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL AGING; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DISSOCIATION CONSTANT; DRUG STRUCTURE; EMBRYONAL CARCINOMA STEM CELL; HUMAN; HUMAN CELL; MITOSIS INHIBITION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL AGING; CELL DIVISION; CELL LINE; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CULTURE MEDIA; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYONAL CARCINOMA STEM CELLS; HUMANS; SOLUBILITY; SUBCELLULAR FRACTIONS; TIME FACTORS;

EID: 84862752615     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039568     Document Type: Article

References (112)

1. Aggarwal BB, Sung B, (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30: 85-94.
2. Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, et al. (2008) Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 76: 1590-1611.
3. Epstein J, Sanderson IR, Macdonald TT, (2010) Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 103: 1545-1557.
4. Villegas I, Sanchez-Fidalgo S, Alarcon de la Lastra C, (2008) New mechanisms and therapeutic potential of curcumin for colorectal cancer. Mol Nutr Food Res 52: 1040-1061.
5. Thangapazham RL, Sharma A, Maheshwari RK, (2006) Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 8: E443-449.
6. Braga ME, Leal PF, Carvalho JE, Meireles MA, (2003) Comparison of yield, composition, and antioxidant activity of turmeric (Curcuma longa L.) extracts obtained using various techniques. J Agric Food Chem 51: 6604-6611.
7. Verghese J, (1993) Isolation of Curcumin from Curcuma longa L. Rhizome. Flavour Fragr J 8: 315-319.
8. Hiserodt R, Hartman TG, Ho C-T, Rosen RT, (1996) Characterization of powdered turmeric by liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry. J Chromatogr A 740: 51-63.
9. Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK, (2002) Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin. J Agric Food Chem 50: 3668-3672.
10. Tayyem RF, Heath DD, Al-Delaimy WK, Rock CL, (2006) Curcumin content of turmeric and curry powders. Nutr Cancer 55: 126-131.
11. Huang MT, Ma W, Lu YP, Chang RL, Fisher C, et al. (1995) Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 16: 2493-2497.
12. Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, et al. (2007) Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol 60: 171-177.
13. Quitschke WW, (2008) Differential solubility of curcuminoids in serum and albumin solutions: implications for analytical and therapeutic applications. BMC Biotechnol 8: 84.
14. Andrews PW, (1998) Teratocarcinomas and human embryology: pluripotent human EC cell lines. Review article. APMIS 106: 158-167; discussion 167-158.
15. Tripathi R, Samadder T, Gupta S, Surolia A, Shaha C, (2011) Anticancer activity of a combination of cisplatin and fisetin in embryonal carcinoma cells and xenograft tumors. Mol Cancer Ther 10: 255-268.
16. Aouida M, Poulin R, Ramotar D, (2010) The human carnitine transporter SLC22A16 mediates high affinity uptake of the anticancer polyamine analogue bleomycin-A5. J Biol Chem 285: 6275-6284.
17. Knower KC, Kelly S, Ludbrook LM, Bagheri-Fam S, Sim H, et al. (2011) Failure of SOX9 regulation in 46XY disorders of sex development with SRY, SOX9 and SF1 mutations. PLoS One 6: e17751.
18. Bayreuther K, Rodemann HP, Hommel R, Dittmann K, Albiez M, et al. (1988) Human skin fibroblasts in vitro differentiate along a terminal cell lineage. Proc Natl Acad Sci U S A 85: 5112-5116.
19. Cristofalo VJ, Pignolo RJ, (1993) Replicative senescence of human fibroblast-like cells in culture. Physiol Rev 73: 617-638.
20. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92: 9363-9367.
21. Kurz DJ, Decary S, Hong Y, Erusalimsky JD, (2000) Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci 113 (Pt 20): 3613-3622.
22. Dujic J, Kippenberger S, Hoffmann S, Ramirez-Bosca A, Miquel J, et al. (2007) Low concentrations of curcumin induce growth arrest and apoptosis in skin keratinocytes only in combination with UVA or visible light. J Invest Dermatol 127: 1992-2000.
23. Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, et al. (2010) Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 79: 330-338.
24. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, et al. (1997) Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15: 1867-1876.
25. Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, et al. (1984) Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 50: 147-162.
26. Dormeyer W, van Hoof D, Braam SR, Heck AJ, Mummery CL, et al. (2008) Plasma membrane proteomics of human embryonic stem cells and human embryonal carcinoma cells. J Proteome Res 7: 2936-2951.
27. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV, (2008) Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65: 1631-1652.
28. Bangaru ML, Woodliff J, Raff H, Kansra S, (2010) Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease. PLoS One 5: e9893.
29. Li L, Braiteh FS, Kurzrock R, (2005) Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104: 1322-1331.
30. Liu Q, Loo WT, Sze SC, Tong Y, (2009) Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription. Phytomedicine 16: 916-922.
31. LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, et al. (2005) Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 11: 6994-7002.
32. Philip S, Kundu GC, (2003) Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem 278: 14487-14497.
33. Purkayastha S, Berliner A, Fernando SS, Ranasinghe B, Ray I, et al. (2009) Curcumin Blocks Brain Tumor Formation. Brain Res.
34. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, et al. (2007) Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28: 1765-1773.
35. Schaaf C, Shan B, Onofri C, Stalla GK, Arzt E, et al. (2010) Curcumin inhibits the growth, induces apoptosis and modulates the function of pituitary folliculostellate cells. Neuroendocrinology 91: 200-210.
36. Shishodia S, Amin HM, Lai R, Aggarwal BB, (2005) Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70: 700-713.
37. Youn HS, Saitoh SI, Miyake K, Hwang DH, (2006) Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem Pharmacol 72: 62-69.
38. Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, et al. (2007) Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 72: 29-39.
39. Johnson SM, Gulhati P, Arrieta I, Wang X, Uchida T, et al. (2009) Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. Anticancer Res 29: 3185-3190.
40. Shen G, Xu C, Hu R, Jain MR, Gopalkrishnan A, et al. (2006) Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin. Mol Cancer Ther 5: 39-51.
41. Charoensuk L, Pinlaor P, Prakobwong S, Hiraku Y, Laothong U, et al. (2011) Curcumin induces a nuclear factor-erythroid 2-related factor 2-driven response against oxidative and nitrative stress after praziquantel treatment in liver fluke-infected hamsters. Int J Parasitol.
42. Balstad TR, Carlsen H, Myhrstad MC, Kolberg M, Reiersen H, et al. (2011) Coffee, broccoli and spices are strong inducers of electrophile response element-dependent transcription in vitro and in vivo- Studies in electrophile response element transgenic mice. Mol Nutr Food Res 55: 185-197.
43. Natarajan VT, Singh A, Kumar AA, Sharma P, Kar HK, et al. (2010) Transcriptional Upregulation of Nrf2-Dependent Phase II Detoxification Genes in the Involved Epidermis of Vitiligo Vulgaris. J Invest Dermatol.
44. Kim AN, Jeon WK, Lee JJ, Kim BC, (2010) Up-regulation of heme oxygenase-1 expression through CaMKII-ERK1/2-Nrf2 signaling mediates the anti-inflammatory effect of bisdemethoxycurcumin in LPS-stimulated macrophages. Free Radic Biol Med 49: 323-331.
45. Demirovic D, Rattan SI, (2011) Curcumin induces stress response and hormetically modulates wound healing ability of human skin fibroblasts undergoing ageing in vitro. Biogerontology.
46. Aggarwal BB, (2010) Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr 30: 173-199.
47. Heng MC, (2010) Curcumin targeted signaling pathways: basis for anti-photoaging and anti-carcinogenic therapy. Int J Dermatol 49: 608-622.
48. Ravindran J, Prasad S, Aggarwal BB, (2009) Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11: 495-510.
49. Sarkar FH, Li Y, Wang Z, Kong D, (2009) Cellular signaling perturbation by natural products. Cell Signal 21: 1541-1547.
50. Wilken R, Veena MS, Wang MB, Srivatsan ES, (2011) Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 10: 12.
51. Zhou H, Beevers CS, Huang S, (2011) The targets of curcumin. Curr Drug Targets 12: 332-347.
52. Scapagnini G, Sonya V, Nader AG, Calogero C, Zella D, et al. (2011) Modulation of Nrf2/ARE Pathway by Food Polyphenols: A Nutritional Neuroprotective Strategy for Cognitive and Neurodegenerative Disorders. Mol Neurobiol.
53. Premanand C, Rema M, Sameer MZ, Sujatha M, Balasubramanyam M, (2006) Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions. Invest Ophthalmol Vis Sci 47: 2179-2184.
54. Bielak-Zmijewska A, Sikora-Polaczek M, Nieznanski K, Mosieniak G, Kolano A, et al. (2010) Curcumin disrupts meiotic and mitotic divisions via spindle impairment and inhibition of CDK1 activity. Cell Prolif 43: 354-364.
55. Chen CC, Hsieh MS, Hsuuw YD, Huang FJ, Chan WH, (2010) Hazardous Effects of Curcumin on Mouse Embryonic Development through a Mitochondria-Dependent Apoptotic Signaling Pathway. Int J Mol Sci 11: 2839-2855.
56. Wu JY, Lin CY, Lin TW, Ken CF, Wen YD, (2007) Curcumin affects development of zebrafish embryo. Biol Pharm Bull 30: 1336-1339.
57. Huang TY, Tsai TH, Hsu CW, Hsu YC, (2010) Curcuminoids suppress the growth and induce apoptosis through caspase-3-dependent pathways in glioblastoma multiforme (GBM) 8401 cells. J Agric Food Chem 58: 10639-10645.
58. Magalska A, Brzezinska A, Bielak-Zmijewska A, Piwocka K, Mosieniak G, et al. (2006) Curcumin induces cell death without oligonucleosomal DNA fragmentation in quiescent and proliferating human CD8+ cells. Acta Biochim Pol 53: 531-538.
59. Shu JC, He YJ, Lv X, Zhao JR, Zhao J, et al. (2009) Effect of curcumin on the proliferation and apoptosis of hepatic stellate cells. Braz J Med Biol Res 42: 1173-1178.
60. Sikora E, Bielak-Zmijewska A, Magalska A, Piwocka K, Mosieniak G, et al. (2006) Curcumin induces caspase-3-dependent apoptotic pathway but inhibits DNA fragmentation factor 40/caspase-activated DNase endonuclease in human Jurkat cells. Mol Cancer Ther 5: 927-934.
61. Martinon F, Tschopp J, (2007) Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14: 10-22.
62. Kumar S, (2007) Caspase function in programmed cell death. Cell Death Differ 14: 32-43.
63. Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T, Vandenabeele P, (2007) Caspases in cell survival, proliferation and differentiation. Cell Death Differ 14: 44-55.
64. Staal J, Bekaert T, Beyaert R, (2011) Regulation of NF-kappaB signaling by caspases and MALT1 paracaspase. Cell Res 21: 40-54.
65. Shinojima N, Yokoyama T, Kondo Y, Kondo S, (2007) Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy 3: 635-637.
66. Teiten MH, Gaascht F, Cronauer M, Henry E, Dicato M, et al. (2011) Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway. Int J Oncol 38: 603-611.
67. O'Sullivan-Coyne G, O'Sullivan GC, O'Donovan TR, Piwocka K, McKenna SL, (2009) Curcumin induces apoptosis-independent death in oesophageal cancer cells. Br J Cancer 101: 1585-1595.
68. Piwocka K, Zablocki K, Wieckowski MR, Skierski J, Feiga I, et al. (1999) A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. Exp Cell Res 249: 299-307.
69. Gautam SC, Xu YX, Pindolia KR, Janakiraman N, Chapman RA, (1998) Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane). Biochem Pharmacol 55: 1333-1337.
70. Kitazumi I, Tsukahara M, (2011) Regulation of DNA fragmentation: the role of caspases and phosphorylation. FEBS J 278: 427-441.
71. Jaruga E, Salvioli S, Dobrucki J, Chrul S, Bandorowicz-Pikula J, et al. (1998) Apoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes. FEBS Lett 433: 287-293.
72. Kunwar A, Barik A, Mishra B, Rathinasamy K, Pandey R, et al. (2008) Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochim Biophys Acta 1780: 673-679.
73. Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, et al. (2006) Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 8: 1291-1297.
74. Besancenot R, Chaligné R, Tonetti C, Pasquier F, Marty C, et al. (2010) A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation. PLoS Biol 8.
75. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS, (2010) The essence of senescence. Genes Dev 24: 2463-2479.
76. Ben-Porath I, Weinberg RA, (2005) The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 37: 961-976.
77. Ohtani N, Yamakoshi K, Takahashi A, Hara E, (2004) The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. J Med Invest 51: 146-153.
78. Dempe JS, Pfeiffer E, Grimm AS, Metzler M, (2008) Metabolism of curcumin and induction of mitotic catastrophe in human cancer cells. Mol Nutr Food Res 52: 1074-1081.
79. Aggarwal BB, Sundaram C, Malani N, Ichikawa H, (2007) Curcumin: the Indian solid gold. Adv Exp Med Biol 595: 1-75.
80. Simons K, Sampaio JL, (2011) Membrane organization and lipid rafts. Cold Spring Harb Perspect Biol 3: a004697.
81. Simons K, Toomre D, (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1: 31-39.
82. Delmas D, Lin HY, (2011) Role of membrane dynamics processes and exogenous molecules in cellular resveratrol uptake: consequences in bioavailability and activities. Mol Nutr Food Res 55: 1142-1153.
83. Pulla Reddy AC, Sudharshan E, Appu Rao AG, Lokesh BR, (1999) Interaction of curcumin with human serum albumin-a spectroscopic study. Lipids 34: 1025-1029.
84. Leung MH, Kee TW, (2009) Effective stabilization of curcumin by association to plasma proteins: human serum albumin and fibrinogen. Langmuir 25: 5773-5777.
85. Blasius R, Duvoix A, Morceau F, Schnekenburger M, Delhalle S, et al. (2004) Curcumin stability and its effect on glutathione S-transferase P1-1 mRNA expression in K562 cells. Ann N Y Acad Sci 1030: 442-448.
86. Bartik L, Whitfield GK, Kaczmarska M, Lowmiller CL, Moffet EW, et al. (2010) Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. J Nutr Biochem 21: 1153-1161.
87. Nangia AK, Hill O, Waterman MD, Schwender CE, Memoli V, (2007) Testicular maturation arrest to testis cancer: spectrum of expression of the vitamin D receptor and vitamin D treatment in vitro. J Urol 178: 1092-1096.
88. Norman AW, Mizwicki MT, Norman DP, (2004) Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3: 27-41.
89. Hoehle SI, Pfeiffer E, Solyom AM, Metzler M, (2006) Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. J Agric Food Chem 54: 756-764.
90. Ireson CR, Jones DJ, Orr S, Coughtrie MW, Boocock DJ, et al. (2002) Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11: 105-111.
91. Péret-Almeida L, Cherubino APF, Alves RJ, Dufossé L, Glória MBA, (2005) Separation and determination of the physico-chemical characteristics of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Research International 38: 1039-1044.
92. Itahana K, Campisi J, Dimri GP, (2007) Methods to detect biomarkers of cellular senescence. The senescence-associated β-galactosidase assay. In: Tollefsbol TO, editors. pp. 21-31 editor. Biological Aging: Methods and Protocols. Totowa, NJ Humana Press Inc.
93. Lu C, Song E, Hu DN, Chen M, Xue C, et al. (2010) Curcumin induces cell death in human uveal melanoma cells through mitochondrial pathway. Curr Eye Res 35: 352-360.
94. Liu HL, Chen Y, Cui GH, Zhou JF, (2005) Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation. Acta Pharmacol Sin 26: 603-609.
95. Singh M, Pandey A, Karikari CA, Singh G, Rakheja D, (2010) Cell cycle inhibition and apoptosis induced by curcumin in Ewing sarcoma cell line SK-NEP-1. Med Oncol 27: 1096-1101.
96. Deters M, Knochenwefel H, Lindhorst D, Koal T, Meyer HH, et al. (2008) Different curcuminoids inhibit T-lymphocyte proliferation independently of their radical scavenging activities. Pharm Res 25: 1822-1827.
97. Sahu A, Bora U, Kasoju N, Goswami P, (2008) Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater 4: 1752-1761.
98. Malik M, Mendoza M, Payson M, Catherino WH, (2009) Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression. Fertil Steril 91: 2177-2184.
99. Lin L, Fuchs J, Li C, Olson V, Bekaii-Saab T, et al. (2011) STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH/CD133 stem cell-like human colon cancer cells. Biochem Biophys Res Commun 416: 246-251.
100. Anuchapreeda S, Thanarattanakorn P, Sittipreechacharn S, Chanarat P, Limtrakul P, (2006) Curcumin inhibits WT1 gene expression in human leukemic K562 cells. Acta Pharmacol Sin 27: 360-366.
101. Lu JJ, Cai YJ, Ding J, (2012) The short-time treatment with curcumin sufficiently decreases cell viability, induces apoptosis and copper enhances these effects in multidrug-resistant K562/A02 cells. Mol Cell Biochem 360: 253-260.
102. Abas F, Hui LS, Ahmad S, Stanslas J, Israf DA, et al. (2006) Biological evaluation of curcumin and related diarylheptanoids. Z Naturforsch C 61: 625-631.
103. Yue GG, Chan BC, Hon PM, Lee MY, Fung KP, et al. (2010) Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa. Food Chem Toxicol 48: 2011-2020.
104. Ding ZS, Jiang FS, Chen NP, Lv GY, Zhu CG, (2008) Isolation and identification of an anti-tumor component from leaves of Impatiens balsamina. Molecules 13: 220-229.
105. Zhou QM, Wang XF, Liu XJ, Zhang H, Lu YY, et al. (2011) Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo. Acta Pharmacol Sin 32: 1402-1410.
106. Moiseeva EP, Almeida GM, Jones GD, Manson MM, (2007) Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol Cancer Ther 6: 3071-3079.
107. Siwak DR, Shishodia S, Aggarwal BB, Kurzrock R, (2005) Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 104: 879-890.
108. Walters DK, Muff R, Langsam B, Born W, Fuchs B, (2008) Cytotoxic effects of curcumin on osteosarcoma cell lines. Invest New Drugs 26: 289-297.
109. Skommer J, Wlodkowic D, Pelkonen J, (2006) Cellular foundation of curcumin-induced apoptosis in follicular lymphoma cell lines. Exp Hematol 34: 463-474.
110. Lünenbürger H, Lanvers-Kaminsky C, Lechtape B, Fruhwald MC, (2010) Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines. Anticancer Drugs 21: 514-522.
111. Cen L, Hutzen B, Ball S, DeAngelis S, Chen CL, et al. (2009) New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells. BMC Cancer 9: 99.
112. Friedman L, Lin L, Ball S, Bekaii-Saab T, Fuchs J, et al. (2009) Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells. Anticancer Drugs 20: 444-449.